Close Menu
Call Us 24/7 Call 24/7 (800) 477-7510
Call 24/7 (800) 477-7510

Drug Injury and Defective Medical Devices

Abilify® Linked With Compulsive Behavior

Abilify® (aripiprazole), a prescription drug used to treat patients suffering from depression, bipolar disorder, schizophrenia, and Tourette syndrome, has been linked with pathological behavior, including compulsive gambling and hypersexual activity far beyond a patient’s typical lifestyle choices or moral code. These compulsions can cause irreparable financial and emotional damage that tears apart families, destroy careers, and permanently damage reputations.

If you took Abilify and developed a gambling problem resulting in serious financial losses or bankruptcy, or you suffered from hypersexuality causing domestic, professional, or even criminal consequences, you may be entitled to compensation. At Norris Injury Lawyers, our drug injury attorneys are ready to review your case and help you take action now. Give us a call at (800) 477-7510 or fill out our free initial consultation form to get started.

Abilify® and Compulsive Behavior Risks

Abilify works by balancing levels of serotonin and dopamine in patients’ brains. But Abilify may over-stimulate the reward system in the brain causing patients to develop an impulse control disorder.

Research published by the British Journal of Psychology links taking Abilify to an increased risk of compulsive gambling–regardless of a patient’s prior history of gambling.

Additionally, a report published by the National Institutes of Health suggests that patients taking Abilify may experience more frequent and extreme sexual desires far beyond their normal lifestyle choices. These reports are from patients with no prior history of hypersexual activity.

Compulsive behaviors associated with Abilify can have severe, life-altering consequences for patients and their loved ones, such as:

  • Bankruptcy
  • Divorce
  • Damaged reputation
  • Severe debt
  • Unemployment
  • Home foreclosure
  • Emotional trauma

FDA Orders Abilify® Compulsive Behavior Drug Warning

According to a May 2016 drug safety communication released by the FDA, Abilify drug packaging will now warn doctors and patients of the potential risk of experiencing compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex while taking the drug. FDA officials state these impulse control problems usually subside soon after patients stop taking Abilify or reduce its dosage.

You May Have an Abilify® Claim

If you or a loved one took Abilify and suffered life-altering financial losses or bankruptcy due to compulsive gambling, or you experienced domestic, professional, or even criminal consequences due to extreme sexual behavior, we want to help. With more than 40 years of experience helping injury victims, we have the knowledge and resources to take on large pharmaceutical companies.

Our No Fee Guarantee® means we’ll evaluate your claim at no cost to you, and we won’t charge any legal fees unless we get compensation for you. Give us a call at (800) 477-7510 or fill out our free initial consultation form to get help now.

Abilify® is a registered trademark of Bristol-Myers Squibb and Otsuka America Pharmaceutical, and is used here only to identify the product in question.

This law firm is not associated with, sponsored by, or affiliated with Bristol-Myers Squibb Company; The British Journal of Psychology; The National Institutes of Health; Otsuka America Pharmaceutical; Otsuka Pharmaceutical Co., Ltd.; or the U.S. Food and Drug Administration.